Clinical trial

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

NCT00004846

Study summary

ClinicalTrials.gov

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention ABC/Gen-Probe/Chiron HIV-1/HCV 001 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date1999-12-01

PhaseN/A

Conditions

Hepatitis Cunresolved

HIV Infectionverified · MONDO: HIV infectious disease

Interventions

ABC/Gen-Probe/Chiron HIV-1/HCV 001DRUG

Sponsors & collaborators

National Institutes of Health Clinical Center (CC)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00004846 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.